Prenatal diagnosis of chromosome abnormalities: A 13-year institution experience

Diagnostics

Volumn 2, Issue 4, 2012, Pages 57-71

  Comas, Carmen ^a   Echevarria, Mónica ^a   Rodríguez, María Ángeles ^a   Rodríguez, Ignacio ^a   Serra, Bernat ^a   Cirigliano, Vincenzo ^b  

^a INSTITUT UNIVERSITARI DEXEUS   (Spain)

^b Biochemical and Molecular Genetics Service   (Spain)

Author keywords

Chromosome abnormality; Down syndrome; Prenatal invasive test; Screening

Indexed keywords

ADULT; ANEUPLOIDY; ANXIETY; ARTICLE; AUTOSOME MOSAICISM; CHORION VILLUS SAMPLING; CHROMOSOME ABERRATION; CHROMOSOME TRANSLOCATION; DOWN SYNDROME; FEMALE; FETUS KARYOTYPING; FIRST TRIMESTER PREGNANCY; GENETIC SCREENING; HUMAN; INVASIVE PROCEDURE; KLINEFELTER SYNDROME; MAJOR CLINICAL STUDY; MATERNAL ATTITUDE; PRENATAL DIAGNOSIS; PRENATAL SCREENING; RETROSPECTIVE STUDY; RISK ASSESSMENT; SEX CHROMOSOME MOSAICISM; TREND STUDY; TRIPLOIDY; TRISOMY 13; TRISOMY 18; TURNER SYNDROME;

EID: 84986234537     PISSN: None     EISSN: 20754418     Source Type: Journal    
DOI: 10.3390/diagnostics2040057     Document Type: Article

References (30)

1. Sherman, L.; Allen, E.G.; Bean, L.H.; Freeman, S.B. Epidemiology of Down syndrome. Ment Retard Dev. Disabil. Res. Rev. 2007, 13, 221-227.
2. Ogivile, C.M. Prenatal diagnosis for chromosome abnormalities: past, present and future. Pathol. Biol. 2003, 51, 156-160.
3. Lewis, M.; Faed, M.J.; Howie, P.W. Screening for Down's syndrome based on individual risk. BMJ 1991, 7, 551-553.
4. Spencer, K.; Spencer, C.E.; Power, M.; Dawson, C.; Nicolaides, K.H. Screening for chromosomal abnormalities in the first trimester using ultrasound and maternal serum biochemistry in a one-stop clinic: A review of three years prospective experience. BJOG 2003, 110, 281-286.
5. Borrell, A.; Casals, E.; Fortuny, A.; Farre, M.T.; Gonce, A.; Sanchez, A.; Soler, A.; Cararach, V.; Vanrell, J.A. First-trimester screening for trisomy 21 combining biochemistry and ultrasound at individually optimal gestational ages. An interventional study. Prenatal Diag. 2004, 24, 541-545.
6. Comas Gabriel, C.; Echevarria Tellería, M.; Muñoz Prades, A.; Rodríguez García, I.; Carrera Martínez, M.; Serra Zantop, B. Invasive prenatal diagnostic practice: A review of a ten years experience at Dexeus Institut. Prenatal Diag. 2011, 22, 117-127.
7. Ekelund, C.K.; Jørgensen, F.S.; Petersen, O.B.; Sundberg, K.; Tabor, A. Impact of a new national screening policy for Down's syndrome in Denmark: population based cohort study. BMJ 2008, 27, doi: 10.1136/bmj.a2547.
8. Vestergaard, C.H.; Lidegaard, Ø.; Tabor, A. Invasive prenatal diagnostic practice in Denmark 1996 to 2006. Acta Obstet. Gynecol. Scand. 2009, 88, 362-365.
9. Lichtenbelt, K.D.; Alizadeh, B.Z.; Scheffer, P.G.; Stoutenbeek, P.; Schielen, P.C.; Page-Christiaens, L.C.; Schuring-Blom, G.H. Trends in the utilization of invasive prenatal diagnosis in The Netherlands during 2000-2009. Prenatal Diag. 2011, 31, 765-772.
10. Morris, J.K.; Waters, J.J.; de Souza, E. The population impact of screening for Down syndrome: Audit of 19326 invasive diagnostic tests in England and Wales in 2008. Prenatal Diag. 2012, 32, 596-601.
11. Mademont-Soler, I.; Morales, C.; Clusellas, N.; Soler, A.; Sánchez, A. Prenatal cytogenetic diagnosis in Spain: Analysis and evaluation of the results obtained from amniotic fluid samples during the last decade. Eur. J. Obstet. Gynecol. Reprod. Biol. 2011, 157, 156-160.
12. Han, S.H.; An, J.W.; Jeong, G.Y.; Yoon, H.R.; Lee, A.; Yang, Y.H.; Lee, K.P.; Lee, K.R. Clinical and cytogenetic findings on 31,615 mid-trimester amniocenteses. Korean J. Lab. Med. 2008, 28, 378-385.
13. Hassold, T.; Abruzzo, M.; Adkins, K.; Griffin, D.; Merrill, M.; Millie, E.; Saker, D.; Shen, J.; Zaragoza, M. Human aneuploidy: incidence, origin, and etiology. Environ. Mol. Mutagen. 1996, 28, 167-175.
14. Verp, M.S.; Bombard, A.T.; Simpson, J.L.; Elias, S. Parental decision following prenatal diagnosis of fetal chromosome abnormality. Am. J. Med. Genet. 1988, 29, 613-622.
15. Ratcliffe, S. Long-term outcome in children of sex chromosome abnormalities. Arch. Dis. Child. 1999, 80, 192-195.
16. Linden, M.G.; Bender, B.G. Fifty-one prenatally diagnosed children and adolescents with sex chromosome abnormalities. Am. J. Med. Genet. 2002, 110, 11-18.
17. Christian, S.M.; Koehn, D.; Pillay, R.; MacDougall, A.; Wilson, R.D. Parental decisions following prenatal diagnosis of sex chromosome aneuploidy: A trend over time. Prenatal Diag. 2000, 20, 37-40.
18. Hamamy, H.A.; Dahoun, S. Parental decisions following the prenatal diagnosis of sex chromosome abnormalities. Eur. J. Obstet. Gynecol. Reprod. Biol. 2004, 116, 58-62.
19. Shaffer, B.L.; Caughey, A.B.; Norton, M.E. Variation in the decision to terminate pregnancy in the setting of fetal aneuploidy. Prenatal Diag. 2006, 26, 667-671.
20. Lee, C.N.; Lin, S.Y.; Lin, C.H.; Shih, J.C.; Lin, T.H.; Su, Y.N. Clinical utility of array comparative genomic hybridisation for prenatal diagnosis: A cohort study of 3171 pregnancies. BJOG 2012, 119, 1282.
21. Querejeta, M.E.; Nieva, B.; Navajas, J.; Cigudosa, J.C.; Suela, J. Diagnóstico prenatal y array-CGH II: gestaciones de bajo riesgo. Prenatal Diag. 2012, 23, 49-55.
22. Armengol, L.; Nevado, J.; Serra-Juhé, C.; Plaja, A.; Mediano, C.; García-Santiago, F.A.; García-Aragonés, M.; Villa, O.; Mansilla, E.; Preciado, C.; Fernández, L.; Ángeles Mori, M.; García-Pérez, L.; Lapunzina, P.D.; Pérez-Jurado, L.A. Clinical utility of chromosomal microarray analysis in invasive prenatal diagnosis. Hum. Genet. 2012, 131, 513-523.
23. Fiorentino, F.; Caiazzo, F.; Napolitano, S.; Spizzichino, L.; Bono, S.; Sessa, M.T.; Nuccitelli, A.; Biricik, A.; Gordon, A.; Rizzo, G; Baldi, M. Introducing array comparative genomic hybridization into routine prenatal diagnosis practice: A prospective study on over 1000 consecutive clinical cases. Prenatal Diag. 2011, 31, 1270-1282.
24. Breman, A.; Pursley, A.N.; Hixson, P.; Bi, W.; Ward, P.; Bacino, C.A.; Shaw, C.H.; Lupski, J.R.; Beaudet, A.; Patel, A.; Cheung, S.W.; van den Veyver, I. Prenatal chromosomal microarray analysis in a diagnostic laboratory; experience with >1000 cases and review of the literature. Prenatal Diag. 2012, 32, 351-361.
25. Fiorentino, F.; Baldi, M. Re: Microarray application in prenatal diagnosis: A position statement from cytogenetics working group of the Italian Society of Human Genetics (SIGU), Novemebr 2011. Ultrasound Obstet. Gynecol. 2012, 39, 601-602.
26. Hillman, S.C.; Pretlove, S.; Coomarasamy, A.; McMullan, D.J.; Davison, E.V.; Maher, E.R.; Kilby, M.D. Additional information from array comparative genomic hybridization technology over conventional karyotyping in prenatal diagnosis: A systematic review and meta-analysis. Ultrasound Obstet. Gynecol. 2011, 37, 6-14.
27. Novelli, A.; Grati, F.R.; Ballarati, L.; Bernardini, L.; Bizzoco, D.; Camurri, L.; Casalone, R.; Cardarelli, L.; Cavalli, P.; Ciccone, R.; et al. Microarray application in prenatal diagnosis: A position statement from the cytogenetics working group of the Italian Society of Human Genetics (SIGU), November 2011. Ultrasound Obstet. Gynecol. 2012, 39, 384-388.
28. Chiu, R.W.K.; Akolekar, R.; Zheng, Y.W.L.; Leung, T.K.; Sun, H.; Chan, K.C.A.; Lun, F.M.F.; Go, A.T.J.I.; Lau, E.T.; To, W.W.K. et al. Non-invasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing: Large scale validation study. Brit. Med. J. 2011, 342, c7401.
29. Sparks, A.B.; Struble, C.A.; Wang, E.T.; Song. K.; Oliphant, A. Noninvasive prenatal detection and selective analysis of cell-free DNA obtained from maternal blood: Evaluation for trisomy 21 and trisomy 18. Am. J. Obstet. Gynecol. 2012, 206, 319e1-319e9.
30. Norton, M.E.; Brar, H.; Weiss, J.; Karimi, A.; Laurent, L.C.; Caughey, A.B.; Rodriguez, M.H.; Williams, J.; Mitchell, M.E.; Adair, C.D.; et al. Non-Invasive Chromosomal Evaluation (NICE) Study: Results of a multicenter prospective cohort study for detection of fetal trisomy 21 and trisomy 18. Am. J. Obstet. Gynecol. 2012, 207, 137e1-137e8.